The recent availability of multiple Clostridiumbotulinum genomic sequences has initiated 3 a new genomics era that strengthens our understanding of the bacterial species that 4 producebotulinum neurotoxins (BoNTs)). Analysis of the genomes has reinforced the historical 5 Group I-VI designations and provided evidence that the bont genes can be located within the 6 chromosome, phage or plasmids. The sequences provide the opportunity to examine closely the 7 variation among the toxin genes, the composition and organization of the toxin complex, the 8 regions flanking the toxin complex and the location of the toxin within different bacterial strains. 
Introduction

23
Clostridiumbotulinum is a species that is defined by the production of any one ofeight 24 serologically distinct botulinum neurotoxins designated BoNT/A-H (Peck, 2009 ). The toxin is a 25 zinc metalloprotease that consists of a light chain, heavy chain and translocation domain. The 26 three domains interact with accessory proteins of the toxin complex to assist the holotoxin in 27 entering the bloodstream, then neuronal cells (Fujinaga et al., 2013) . Once inside the neuronal 28 cells the light chain domain cleaves specific sites within SNARE proteins. The cleavage of these 29 proteinsprevents the release of acetylcholine into the neuronal muscular junction and results in a 30 flaccid paralysis known as botulism (Schiavo et al., 1995) . 31 The BoNT-producingbacteria are generally calledC. botulinum, but they could be 32 considered six different species by 16S rrn comparisons (Hill et al., 2009 ). Group I-IV 33 designations are used to distinguish the different species within C. botulinum.TheC. botulinumGroup IV (also designated C. argentinense)strains produceBoNT/G. Group V retained 37 the species name of C. baratiifor strains that produceBoNT/F and Group IV are C. 38 butyricumstrains that produceBoNT/E (Popoff and Marvaud, 1999) . The presence of the same 39 toxin type in different Groups/species indicates that the toxin (and its associated genes within the 40 toxin complex) move into different bacterial species by horizontal gene transfer(HGT). 41 The eight BoNTs (A-H) proteins are serologically distinct and differ by 37 to 70% in differences may be minor (1-7% difference among type B) or major (3-36% among type F) (Hill 48 and Smith, 2013) . The subtypes are given the toxin letter designation followed by a number. For 
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Locations of the bont genes within the Group I plasmids are also conserved ( Figure 3 ).
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The Group I plasmids vary in size (~150-270 kb), but often show significant regions of synteny.
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In addition to thebont/Agenes locatedwithin Group I plasmids, there is a second location that is Bh strain, IBCA10-0760, is at the oppA/brnQ site (Figure 3 ) (Dover et al., 2014b resolvase,encoded by the rarA genethat is a recombinase associated with transposases ( Figure 3 ).
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In the BoNT/E-producingC. botulinum and C butyricum, the rarA gene appears to find a interest that the same insertion mechanism is used by multiple BoNT/E and /F subtypes from C.
223
botulinum Group I and Group II,and Group VI C. butyricum strains. Antnh genesremoved the bont/A1 from its orfX+ gene cluster and placed it within the ha+ toxin 
